HealthSouth Corp (NYSE:HLS) has earned an average recommendation of “Buy” from the ten research firms that are covering the firm. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating on the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $47.92.
Several research analysts have weighed in on HLS shares. Craig Hallum started coverage on HealthSouth Corp in a research note on Monday, February 13th. They issued a “buy” rating and a $48.00 target price on the stock. Royal Bank of Canada lifted their target price on HealthSouth Corp from $48.00 to $50.00 and gave the company an “outperform” rating in a research note on Monday, February 27th. Stephens upgraded HealthSouth Corp from an “equal weight” rating to an “overweight” rating in a research note on Wednesday, February 22nd. Mizuho lifted their price target on HealthSouth Corp from $38.00 to $44.50 and gave the company a “neutral” rating in a research note on Wednesday, February 22nd. Finally, Zacks Investment Research downgraded HealthSouth Corp from a “hold” rating to a “sell” rating in a research note on Tuesday, April 25th.
Shares of HealthSouth Corp (NYSE:HLS) traded down 1.62% during midday trading on Tuesday, reaching $45.54. The company had a trading volume of 689,920 shares. The company’s 50 day moving average price is $44.75 and its 200 day moving average price is $42.08. The stock has a market capitalization of $4.08 billion, a PE ratio of 17.01 and a beta of 0.85. HealthSouth Corp has a 52-week low of $36.97 and a 52-week high of $47.88.
HealthSouth Corp (NYSE:HLS) last announced its earnings results on Thursday, April 27th. The company reported $0.70 earnings per share for the quarter, beating the consensus estimate of $0.65 by $0.05. HealthSouth Corp had a return on equity of 29.27% and a net margin of 6.31%. The company had revenue of $974.80 million for the quarter, compared to the consensus estimate of $960.05 million. During the same period last year, the business posted $0.61 EPS. The company’s revenue was up 7.1% on a year-over-year basis. Equities research analysts expect that HealthSouth Corp will post $2.70 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 17th. Investors of record on Monday, July 3rd will be issued a dividend of $0.24 per share. The ex-dividend date of this dividend is Thursday, June 29th. This represents a $0.96 annualized dividend and a yield of 2.11%. HealthSouth Corp’s dividend payout ratio is presently 40.17%.
TRADEMARK VIOLATION NOTICE: This piece was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.com-unik.info/2017/05/17/healthsouth-corp-hls-given-consensus-rating-of-buy-by-brokerages-updated-updated-updated.html.
A number of institutional investors have recently modified their holdings of HLS. Paloma Partners Management Co boosted its position in HealthSouth Corp by 98.0% in the first quarter. Paloma Partners Management Co now owns 48,049 shares of the company’s stock worth $2,057,000 after buying an additional 23,776 shares during the period. AQR Capital Management LLC boosted its position in HealthSouth Corp by 3.2% in the first quarter. AQR Capital Management LLC now owns 70,913 shares of the company’s stock worth $3,036,000 after buying an additional 2,192 shares during the period. Gotham Asset Management LLC bought a new position in HealthSouth Corp during the first quarter worth $2,877,000. Schwab Charles Investment Management Inc. boosted its position in HealthSouth Corp by 16.0% in the first quarter. Schwab Charles Investment Management Inc. now owns 637,269 shares of the company’s stock worth $27,282,000 after buying an additional 88,119 shares during the period. Finally, Epoch Investment Partners Inc. boosted its position in HealthSouth Corp by 62.9% in the first quarter. Epoch Investment Partners Inc. now owns 611,991 shares of the company’s stock worth $26,199,000 after buying an additional 236,398 shares during the period. 98.89% of the stock is owned by hedge funds and other institutional investors.
About HealthSouth Corp
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
What are top analysts saying about HealthSouth Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HealthSouth Corp and related companies.